PAA 10.3% 37.5¢ pharmaust limited

I agree MM, it's stupidly cheap for a company that has built up...

  1. 2,307 Posts.
    lightbulb Created with Sketch. 1429
    I agree MM, it's stupidly cheap for a company that has built up so much IP in the drugs Albendazole and MPL and the progress being made by Epichem. But markets are like that, fickle, and past disappointments hang around like a bad smell. What this market is looking is for something to break it out of that emotional rut. A clear breakthrough in the palatability issues and re-commencement of ph 2 would probably do that as would continued improvement in finances from Epichem.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.035(10.3%)
Mkt cap ! $147.7M
Open High Low Value Volume
34.5¢ 38.0¢ 34.5¢ $542.7K 1.474M

Buyers (Bids)

No. Vol. Price($)
1 22900 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 18443 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
37.0¢
  Change
0.035 ( 8.82 %)
Open High Low Volume
34.5¢ 38.0¢ 34.5¢ 757697
Last updated 15.59pm 29/03/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.